Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse model

201686 citationsJournal Article

Authors

Good health and well-being

Published in: Cancer Letters

Volume 372, Issue 2, pp. 179-186

Field-Weighted Citation Impact: 7.63